Go to deals
Agriculture | Consumer & Retail | Food & Beverage | Healthcare

InVivo NSA has acquired AdGène

InVivo NSA has acquired AdGène for US$8 million.

InVivo NSA, along with its subsidiaries, engages in complete feed, premix, additives, analysis laboratories, and animal health businesses in Central America, South America, France/EMEA, and Asia. InVivo Labs, the analytical division of InVivo NSA, and AdGène, an expert laboratory in molecular biology in France, have announced their strategic union. This transaction allows InVivo Labs to reinforce its analytical portfolio related to food safety and traceability. Moreover, it positions the new group as a significant player in the high potential growing market of bioanalysis.

Founded in 2001, AdGène is a French laboratory that specializes in molecular biology, genetic analyses and water quality control. The laboratory employs 20 people and has high-tech equipment.

Oaklins' team in France advised the buyer in this transaction.

Parties

Talk to the deal team

 Thibaut  de Monclin

Thibaut de Monclin

Managing Partner
Paris, France
Oaklins France

Related deals

MBO of Norway’s leading service and technology provider for food production
Food & Beverage

MBO of Norway’s leading service and technology provider for food production

Tine and Nortura have sold Skala Gruppen AS to the management team.

Learn more
Prestige Inhome Care has found a long-term strategic partner
Healthcare

Prestige Inhome Care has found a long-term strategic partner

Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.

Learn more
Cara Care has been acquired by Mahana Therapeutics
Private Equity | Healthcare | TMT

Cara Care has been acquired by Mahana Therapeutics

Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.

Learn more